Linwong Watchara, Hirasawa Noriyasu, Aoyama Suzue, Hamada Hirofumi, Saito Takashi, Ohuchi Kazuo
Laboratory of Pathophysiological Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan.
Br J Pharmacol. 2005 Jul;145(6):818-28. doi: 10.1038/sj.bjp.0706240.
We analyzed the effects of the Janus kinase 3 (Jak3)-specific inhibitor WHI-P131 (4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline) and the Jak3/Syk inhibitor WHI-P154 (4-(3'-bromo-4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline) on the antigen-induced activation of mast cells. In the rat mast cell line RBL-2H3, both WHI-P131 and WHI-P154 inhibited the antigen-induced degranulation and phosphorylation of p44/42 mitogen-activated protein kinase (MAPK), p38 MAPK and c-Jun N-terminal kinase (JNK). The phosphorylation of Gab2, Akt and Vav was also inhibited by WHI-P131 and WHI-P154, indicating that these inhibitors suppress the activation of phosphatidylinositol 3-kinase (PI3K). In bone marrow-derived mast cells (BMMCs) from Jak3-deficient (Jak3-/-) mice, degranulation and activation of MAPKs were induced by the antigen in almost the same extent as in BMMCs from wild-type mice. In addition, the antigen-induced degranulation and activation of MAPKs were inhibited by WHI-P131 and WHI-P154 in both groups of BMMCs, indicating that these compounds inhibit a certain step except for Jak3. The antigen-induced increase in the activity of Fyn, a probable tyrosine kinase of Gab2, was also inhibited by WHI-P131 and WHI-P154 in RBL-2H3 cells. In BMMCs from Jak3-/- mice, the antigen stimulation induced tyrosine phosphorylation of Fyn, which was inhibited by WHI-P131, as well as in BMMCs from wild-type mice and in RBL-2H3 cells. These findings suggest that Jak3 does not play a significant role in the antigen-induced degranulation and phosphorylation of MAPKs, and that WHI-P131 and WHI-P154 inhibit the PI3K pathway by preventing the antigen-induced activation of Fyn, thus inhibiting the antigen-induced degranulation and phosphorylation of MAPKs in mast cells.
我们分析了Janus激酶3(Jak3)特异性抑制剂WHI-P131(4-(4'-羟基苯基)-氨基-6,7-二甲氧基喹唑啉)和Jak3/Syk抑制剂WHI-P154(4-(3'-溴-4'-羟基苯基)-氨基-6,7-二甲氧基喹唑啉)对抗原诱导的肥大细胞活化的影响。在大鼠肥大细胞系RBL-2H3中,WHI-P131和WHI-P154均抑制抗原诱导的颗粒释放以及p44/42丝裂原活化蛋白激酶(MAPK)、p38 MAPK和c-Jun氨基末端激酶(JNK)的磷酸化。Gab2、Akt和Vav的磷酸化也受到WHI-P131和WHI-P154的抑制,表明这些抑制剂抑制磷脂酰肌醇3激酶(PI3K)的活化。在来自Jak3缺陷(Jak3-/-)小鼠的骨髓源性肥大细胞(BMMC)中,抗原诱导的颗粒释放和MAPK活化程度与野生型小鼠的BMMC几乎相同。此外,两组BMMC中抗原诱导的颗粒释放和MAPK活化均受到WHI-P131和WHI-P154的抑制,表明这些化合物抑制了除Jak3之外的某个步骤。在RBL-2H3细胞中,抗原诱导的Gab2可能的酪氨酸激酶Fyn活性增加也受到WHI-P131和WHI-P154的抑制。在Jak3-/-小鼠的BMMC中,抗原刺激诱导Fyn的酪氨酸磷酸化,在野生型小鼠的BMMC和RBL-2H3细胞中,这种磷酸化受到WHI-P131的抑制。这些发现表明,Jak3在抗原诱导的肥大细胞颗粒释放和MAPK磷酸化中不起重要作用,并且WHI-P131和WHI-P154通过阻止抗原诱导的Fyn活化来抑制PI3K途径,从而抑制肥大细胞中抗原诱导的颗粒释放和MAPK磷酸化。